SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
can please help me with this case study.
can you solve it by the number of the question?
Mr. Ben Zocaine is a 53-year-old male, who weighs 180 pounds. Upon reviewing his medical
history, you find he is taking Losartan 50mg once a day for hypertension. He also taking
Metformin for Type 2 diabetes. He has no known drug allergies. He does not state that he is
anxious about dental treatment, but this is his first time undergoing any type of periodontal
therapy. His homecare is poor. Vitals signs today are BP 135/88, pulse 70 , temp 97.2. He is
scheduled today for 1 hour for NSPT on the upper left quadrant. Pockets generalized are 5mm in
the posteriors, with 7mm pockets on #13-DL and #14-ML, as well as #10-DL and #11ML. 1.
What is Mr. Zocaine's ASA classification? Why? 2. Is there anything in the description above
that would give you concerns for Mr. Zocaine's psychological ability to tolerate treatment? Why
or why not? 3. What stress reduction protocol precautions and modifications would you make in
preparation for and during his appointment? Look at both physical and psychological concems.
5. For scaling the UL quadrant, which rierves would you anesthetize? (Specify R or L ) 6. Based
on the nerves you stated you will anesthetize in question #5, how many cartridges of your chosen
anesthetic will you require to adequately anesthetize your patient? (Specify the amount for each
injection and then give a total dose) 7. Based on your answer in question #6: (please show or
explain your work!) a. How many milligrams of anesthetic will you administer?
8. a. Compute the MRD of the local anesthetic you in cartridges. b. Compute the MRD of the
vasoconstrictor in cartridges. c. Which drug is the limiting factor for Mr. Zocaine? 9. After
anesthetizing your patient, and confirming he is comfortably numb, you begin to work. You find
there is significant bleeding between teeth #1011. How could you address this issue?
Mr. Ben Zecainc is a 53-year-old male, who weighs 180 pounds. Upon reviewing his medical
history, you find he is taking Losartan 50mg once a day for hypertension. He also taking
Metformin for Type 2 diabetes. He has no known drug allergies. He does not state that he is
anxious about dental treatment, but this is his first time undergoing any type of periodontal
therapy. His homecare is poor. Vitals signs today are BP 135/88, pulse 70 , temp 97.2. He is
scheduled today for 1 hour for NSPT on the upper left quadrant. Pockets generalized are 5mm in
the posteriors, with 7mm pockets on #13-DL and #14-ML, as well as #10-DL and #11ML. 1.
What is Mr. Zocaine's ASA classification? Why? 2. Is there anything in the description above
that would give you concerns for Mr. Zocaine's psychological ability to tolerate treatment? Why
or why not? 3. What stress reduction protocol precautions and modifications would you make in
preparation for and during his appointment? Look at both physical and psychological concems.
4. Based on Mr. Zocaine's medical history, select an appropriate anesthetic for today's
procedures. You will require a full hour of working time. Due to edematous tissue, you are also
concerned with hemostasis between #10-11. a. What anesthetic would you choose? Explain your
choice, i.e. what are the medical considerations when choosing? b. Will any dosage
modifications be indicated? 5. For scaling the UL quadrant, which nerves would you
anesthetize? (Specify R or L ) 6. Based on the nerves you stated you will anesthetize in question
#5, how many cartridges of your chosen anesthetic will you require to adequately anesthetize
your patient? (Specify the amount for each injection and then give a total dose)
7. Based on your answer in question #6: (please show or explain your work!) a. How many
milligrams of anesthetic will you administer? b. How many milligrams of vasoconstrictor?
8. a. Compute the MRD of the local anesthetic you in cartridges. b. Compute the MRD of the
vasoconstrictor in cartridges. c. Which drug is the limiting factor for Mr. Zocaine? 9. After
anesthetizing your patient, and confirming he is comfortably numb, you begin to work. You find
there is significant bleeding between teeth #10-11. How could you address this issue?

Contenu connexe

Similaire à can please help me with this case study.can you solve it by the nu.pdf

FIRST PAPERCase Study Mr. M.It is necessary for a.docx
FIRST PAPERCase Study Mr. M.It is necessary for a.docxFIRST PAPERCase Study Mr. M.It is necessary for a.docx
FIRST PAPERCase Study Mr. M.It is necessary for a.docx
clydes2
 
Neurology MedicationsDo not change the format of this handout..docx
Neurology MedicationsDo not change the format of this handout..docxNeurology MedicationsDo not change the format of this handout..docx
Neurology MedicationsDo not change the format of this handout..docx
gertrudebellgrove
 
Pharmacotherapeutics practical
Pharmacotherapeutics practicalPharmacotherapeutics practical
Pharmacotherapeutics practical
Sadagoban G.K
 
Pharmaceutical care plan
Pharmaceutical care planPharmaceutical care plan
Pharmaceutical care plan
Norliza Ariffin
 
Generalized Anxiety DisorderMiddle-Aged White Male With Anxiety.docx
Generalized Anxiety DisorderMiddle-Aged White Male With Anxiety.docxGeneralized Anxiety DisorderMiddle-Aged White Male With Anxiety.docx
Generalized Anxiety DisorderMiddle-Aged White Male With Anxiety.docx
shericehewat
 
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdfCase Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
bkbk37
 

Similaire à can please help me with this case study.can you solve it by the nu.pdf (13)

FIRST PAPERCase Study Mr. M.It is necessary for a.docx
FIRST PAPERCase Study Mr. M.It is necessary for a.docxFIRST PAPERCase Study Mr. M.It is necessary for a.docx
FIRST PAPERCase Study Mr. M.It is necessary for a.docx
 
Neurology MedicationsDo not change the format of this handout..docx
Neurology MedicationsDo not change the format of this handout..docxNeurology MedicationsDo not change the format of this handout..docx
Neurology MedicationsDo not change the format of this handout..docx
 
Adventures in Pharmacopalliation: Cancer Pain Management
Adventures in Pharmacopalliation: Cancer Pain ManagementAdventures in Pharmacopalliation: Cancer Pain Management
Adventures in Pharmacopalliation: Cancer Pain Management
 
case study for Mr and Mr.docx
case study for Mr and Mr.docxcase study for Mr and Mr.docx
case study for Mr and Mr.docx
 
Pharmacotherapeutics practical
Pharmacotherapeutics practicalPharmacotherapeutics practical
Pharmacotherapeutics practical
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
Pharmaceutical care plan
Pharmaceutical care planPharmaceutical care plan
Pharmaceutical care plan
 
Nr 508 Education Organization -- snaptutorial.com
Nr 508   Education Organization -- snaptutorial.comNr 508   Education Organization -- snaptutorial.com
Nr 508 Education Organization -- snaptutorial.com
 
Nr 508 Education Redefined-snaptutorial.com
Nr 508 Education Redefined-snaptutorial.comNr 508 Education Redefined-snaptutorial.com
Nr 508 Education Redefined-snaptutorial.com
 
Generalized Anxiety DisorderMiddle-Aged White Male With Anxiety.docx
Generalized Anxiety DisorderMiddle-Aged White Male With Anxiety.docxGeneralized Anxiety DisorderMiddle-Aged White Male With Anxiety.docx
Generalized Anxiety DisorderMiddle-Aged White Male With Anxiety.docx
 
Labdhi pharmaceuticals
Labdhi pharmaceuticalsLabdhi pharmaceuticals
Labdhi pharmaceuticals
 
Labdhi pharmaceuticals
Labdhi pharmaceuticalsLabdhi pharmaceuticals
Labdhi pharmaceuticals
 
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdfCase Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
Case Pharmacologic Approaches to the Treatment of Insomnia in a.pdf
 

Plus de info189835

Can someone explain me the steps pleaseTake the provided files.pdf
Can someone explain me the steps pleaseTake the provided files.pdfCan someone explain me the steps pleaseTake the provided files.pdf
Can someone explain me the steps pleaseTake the provided files.pdf
info189835
 
Cada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdf
Cada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdfCada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdf
Cada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdf
info189835
 
C++ help finish my code Phase 1 - input phase. Main reads the fi.pdf
C++ help finish my code Phase 1 - input phase. Main reads the fi.pdfC++ help finish my code Phase 1 - input phase. Main reads the fi.pdf
C++ help finish my code Phase 1 - input phase. Main reads the fi.pdf
info189835
 

Plus de info189835 (20)

Can someone help with the implementation of these generic ArrayList .pdf
Can someone help with the implementation of these generic ArrayList .pdfCan someone help with the implementation of these generic ArrayList .pdf
Can someone help with the implementation of these generic ArrayList .pdf
 
can someone help with the implementation of these generic DoublyLink.pdf
can someone help with the implementation of these generic DoublyLink.pdfcan someone help with the implementation of these generic DoublyLink.pdf
can someone help with the implementation of these generic DoublyLink.pdf
 
can someone help with the implementation of these generic LinkedList.pdf
can someone help with the implementation of these generic LinkedList.pdfcan someone help with the implementation of these generic LinkedList.pdf
can someone help with the implementation of these generic LinkedList.pdf
 
Can someone explain me the steps pleaseTake the provided files.pdf
Can someone explain me the steps pleaseTake the provided files.pdfCan someone explain me the steps pleaseTake the provided files.pdf
Can someone explain me the steps pleaseTake the provided files.pdf
 
can someone briefly answer these questions please1) how socia.pdf
can someone briefly answer these questions please1) how socia.pdfcan someone briefly answer these questions please1) how socia.pdf
can someone briefly answer these questions please1) how socia.pdf
 
Can anyone help me to understand why Consider a two way ANOVA model.pdf
Can anyone help me to understand why Consider a two way ANOVA model.pdfCan anyone help me to understand why Consider a two way ANOVA model.pdf
Can anyone help me to understand why Consider a two way ANOVA model.pdf
 
can anyone help Prokaryotes are highly successful biological organi.pdf
can anyone help Prokaryotes are highly successful biological organi.pdfcan anyone help Prokaryotes are highly successful biological organi.pdf
can anyone help Prokaryotes are highly successful biological organi.pdf
 
Cambios en los Activos y Pasivos Operativos Actuales�M�todo Indirect.pdf
Cambios en los Activos y Pasivos Operativos Actuales�M�todo Indirect.pdfCambios en los Activos y Pasivos Operativos Actuales�M�todo Indirect.pdf
Cambios en los Activos y Pasivos Operativos Actuales�M�todo Indirect.pdf
 
California condors (Gymnogyps californianus) are listed on the IUCN .pdf
California condors (Gymnogyps californianus) are listed on the IUCN .pdfCalifornia condors (Gymnogyps californianus) are listed on the IUCN .pdf
California condors (Gymnogyps californianus) are listed on the IUCN .pdf
 
California continues to face a water shortage. The quantity of water.pdf
California continues to face a water shortage. The quantity of water.pdfCalifornia continues to face a water shortage. The quantity of water.pdf
California continues to face a water shortage. The quantity of water.pdf
 
Calculate the various ratios based on the following informationCa.pdf
Calculate the various ratios based on the following informationCa.pdfCalculate the various ratios based on the following informationCa.pdf
Calculate the various ratios based on the following informationCa.pdf
 
calculate the return on assets calculate the return on equity ca.pdf
calculate the return on assets calculate the return on equity ca.pdfcalculate the return on assets calculate the return on equity ca.pdf
calculate the return on assets calculate the return on equity ca.pdf
 
Calculate the frequency of alleles A and B for the two populations s.pdf
Calculate the frequency of alleles A and B for the two populations s.pdfCalculate the frequency of alleles A and B for the two populations s.pdf
Calculate the frequency of alleles A and B for the two populations s.pdf
 
Calculate the Earnings Per Share (EPS) and Dividends Per Share (DPS).pdf
Calculate the Earnings Per Share (EPS) and Dividends Per Share (DPS).pdfCalculate the Earnings Per Share (EPS) and Dividends Per Share (DPS).pdf
Calculate the Earnings Per Share (EPS) and Dividends Per Share (DPS).pdf
 
Calculate the of total (portfolio weight) for eachStock A pr.pdf
Calculate the  of total (portfolio weight) for eachStock A pr.pdfCalculate the  of total (portfolio weight) for eachStock A pr.pdf
Calculate the of total (portfolio weight) for eachStock A pr.pdf
 
Calculate R2. (Round your answer to 4 decimal places.)Moviegoer Sp.pdf
Calculate R2. (Round your answer to 4 decimal places.)Moviegoer Sp.pdfCalculate R2. (Round your answer to 4 decimal places.)Moviegoer Sp.pdf
Calculate R2. (Round your answer to 4 decimal places.)Moviegoer Sp.pdf
 
Cada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdf
Cada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdfCada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdf
Cada vez es m�s dif�cil mantenerse al d�a con los problemas tecnol�g.pdf
 
Cada una de las siguientes cuentas se reporta como pasivo a largo pl.pdf
Cada una de las siguientes cuentas se reporta como pasivo a largo pl.pdfCada una de las siguientes cuentas se reporta como pasivo a largo pl.pdf
Cada una de las siguientes cuentas se reporta como pasivo a largo pl.pdf
 
C coding into MIPS coding (Make sure this code works on Qtmips) Ho.pdf
C coding into MIPS coding (Make sure this code works on Qtmips) Ho.pdfC coding into MIPS coding (Make sure this code works on Qtmips) Ho.pdf
C coding into MIPS coding (Make sure this code works on Qtmips) Ho.pdf
 
C++ help finish my code Phase 1 - input phase. Main reads the fi.pdf
C++ help finish my code Phase 1 - input phase. Main reads the fi.pdfC++ help finish my code Phase 1 - input phase. Main reads the fi.pdf
C++ help finish my code Phase 1 - input phase. Main reads the fi.pdf
 

Dernier

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Dernier (20)

SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 

can please help me with this case study.can you solve it by the nu.pdf

  • 1. can please help me with this case study. can you solve it by the number of the question? Mr. Ben Zocaine is a 53-year-old male, who weighs 180 pounds. Upon reviewing his medical history, you find he is taking Losartan 50mg once a day for hypertension. He also taking Metformin for Type 2 diabetes. He has no known drug allergies. He does not state that he is anxious about dental treatment, but this is his first time undergoing any type of periodontal therapy. His homecare is poor. Vitals signs today are BP 135/88, pulse 70 , temp 97.2. He is scheduled today for 1 hour for NSPT on the upper left quadrant. Pockets generalized are 5mm in the posteriors, with 7mm pockets on #13-DL and #14-ML, as well as #10-DL and #11ML. 1. What is Mr. Zocaine's ASA classification? Why? 2. Is there anything in the description above that would give you concerns for Mr. Zocaine's psychological ability to tolerate treatment? Why or why not? 3. What stress reduction protocol precautions and modifications would you make in preparation for and during his appointment? Look at both physical and psychological concems. 5. For scaling the UL quadrant, which rierves would you anesthetize? (Specify R or L ) 6. Based on the nerves you stated you will anesthetize in question #5, how many cartridges of your chosen anesthetic will you require to adequately anesthetize your patient? (Specify the amount for each injection and then give a total dose) 7. Based on your answer in question #6: (please show or explain your work!) a. How many milligrams of anesthetic will you administer? 8. a. Compute the MRD of the local anesthetic you in cartridges. b. Compute the MRD of the vasoconstrictor in cartridges. c. Which drug is the limiting factor for Mr. Zocaine? 9. After anesthetizing your patient, and confirming he is comfortably numb, you begin to work. You find there is significant bleeding between teeth #1011. How could you address this issue? Mr. Ben Zecainc is a 53-year-old male, who weighs 180 pounds. Upon reviewing his medical history, you find he is taking Losartan 50mg once a day for hypertension. He also taking Metformin for Type 2 diabetes. He has no known drug allergies. He does not state that he is anxious about dental treatment, but this is his first time undergoing any type of periodontal therapy. His homecare is poor. Vitals signs today are BP 135/88, pulse 70 , temp 97.2. He is scheduled today for 1 hour for NSPT on the upper left quadrant. Pockets generalized are 5mm in the posteriors, with 7mm pockets on #13-DL and #14-ML, as well as #10-DL and #11ML. 1.
  • 2. What is Mr. Zocaine's ASA classification? Why? 2. Is there anything in the description above that would give you concerns for Mr. Zocaine's psychological ability to tolerate treatment? Why or why not? 3. What stress reduction protocol precautions and modifications would you make in preparation for and during his appointment? Look at both physical and psychological concems. 4. Based on Mr. Zocaine's medical history, select an appropriate anesthetic for today's procedures. You will require a full hour of working time. Due to edematous tissue, you are also concerned with hemostasis between #10-11. a. What anesthetic would you choose? Explain your choice, i.e. what are the medical considerations when choosing? b. Will any dosage modifications be indicated? 5. For scaling the UL quadrant, which nerves would you anesthetize? (Specify R or L ) 6. Based on the nerves you stated you will anesthetize in question #5, how many cartridges of your chosen anesthetic will you require to adequately anesthetize your patient? (Specify the amount for each injection and then give a total dose) 7. Based on your answer in question #6: (please show or explain your work!) a. How many milligrams of anesthetic will you administer? b. How many milligrams of vasoconstrictor? 8. a. Compute the MRD of the local anesthetic you in cartridges. b. Compute the MRD of the vasoconstrictor in cartridges. c. Which drug is the limiting factor for Mr. Zocaine? 9. After anesthetizing your patient, and confirming he is comfortably numb, you begin to work. You find there is significant bleeding between teeth #10-11. How could you address this issue?